Lymph Nodes News and Research

RSS

Researchers discover immune regulator that appears to dictate glioblastoma

Researchers at The University of Texas MD Anderson Cancer Center have discovered an immune regulator that appears to dictate glioblastoma progression by shutting down immune surveillance, indicating a potential new area of therapeutic investigation.

28 Jan 2019

Researchers identify marker protein that offers both diagnostic and therapeutic function

Of all gastrointestinal cancers, pancreatic cancer is one of the most aggressive. Because of this, it has a very low 5-year survival rate of just 5% and a median survival time below 6 months. Additionally, treatment is difficult, with only surgery shown to provide a cure. However, the vast majority of patients have tumors that cannot be removed surgically or their cancer is too advanced or spread too far to be treatable.

24 Jan 2019

An essential reference for diagnostic ultrasonography and biopsy of the thyroid gland

The book provides the reader essential information on how to 1) distinguish between normal and abnormal thyroid sonograms, 2) differentiate low suspicion for malignancy thyroid nodules from sonographically high suspicion nodules, 3) evaluate cervical lymph nodes and parathyroid glands, and 4) examine post-thyroidectomy patients with differentiated thyroid cancer.

23 Jan 2019

Breast cancers more likely to metastasize in young women within 10 years of giving birth

A study by researchers at University of Colorado Cancer Center and Oregon Health & Science University published today in the Journal of the American Medical Association Network shows that breast cancers diagnosed in young women within 10 years of giving birth are more likely to metastasize, and thus more likely to cause death, than breast cancers in young women who gave birth less recently or not at all.

17 Jan 2019

Schizophrenia patients have higher levels of antibodies against Epstein-Barr virus, study shows

New research from Johns Hopkins Medicine and Sheppard Pratt Health System shows that people in the study with schizophrenia also have higher levels of antibodies against the Epstein-Barr virus (EBV), a herpes virus that causes infectious mononucleosis, so-called mono.

9 Jan 2019

Yale researchers use arthritis medication to treat patient with disfiguring sarcoidosis

An all-Yale team of researchers successfully treated a patient with disfiguring sarcoidosis, a chronic disease that can affect multiple organs, with a drug approved for rheumatoid arthritis.

26 Dec 2018

FDA approves new treatment for rare disease of the bone marrow and blood

The U.S. Food and Drug Administration today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm in adults and in pediatric patients, two years of age and older.

21 Dec 2018

New data from TAILORx trial confirms lack of chemo benefit regardless of race or ethnicity

An analysis of race and ethnicity data from the TAILORx clinical trial was presented at the 2018 San Antonio Breast Cancer Symposium.

10 Dec 2018

Multigene test is a helpful decision making tool in breast cancer treatment, study shows

Multigene tests have been used in breast cancer treatment to assess the risk of metastasis for several years. A team at the Breast Cancer Center at the Technical University of Munich's Klinikum rechts der Isar has now presented results based on data collected in its routine clinical work.

7 Dec 2018

Earliest strain of plague bacteria found in neolithic Swedish mass grave

Researchers have unearthed a strain of plague bacteria Yersinia pestis, in a woman who was buried in Sweden during the stone ages.

6 Dec 2018

UMGCCC uses Gammapod radiotherapy to treat breast cancer patients

Radiation oncologists at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center are now treating patients with the GammaPod™, a new FDA-cleared radiation therapy for early-stage breast cancer.

6 Dec 2018

Lymph node ratio could predict survival in patients with oral cavity cancer

Five years after diagnosis, only 40 percent of patients with locally-advanced oral cavity cancer will still be alive. The question is who is likely to live and who is likely to die? The answer to this question could not only help patients better predict the course of their disease, but could help doctors choose the most appropriate post-surgical treatments - patients at highest risk could receive the most aggressive combinations of radiation and chemotherapy.

6 Dec 2018

UAB research may point a path to more effective influenza vaccines

Seasonal influenza vaccines are typically less than 50 percent effective, according to Centers for Disease Control and Prevention studies. Research at the University of Alabama at Birmingham, published this week in Nature Immunology, may point a path to more effective vaccines.

6 Dec 2018

First modeling system developed for testing age-specific human immune responses to vaccines

A team of scientists at Boston Children's Hospital has developed the first modeling system for testing age-specific human immune responses to vaccines -- outside the body. The practical, cost-effective new platform, using all human components, is expected to accelerate and de-risk the development, assessment and selection of vaccines.

20 Nov 2018

Precisely targeted prostate cancer radiotherapy possible with nuclear medicine imaging

Current standard imaging techniques for initial staging of prostate cancer often underestimate the extent of disease beyond the prostate.

9 Nov 2018

Advances in radiation treatment help prolong, improve lives of people with anal cancer

Two recent studies find advances in radiation therapy are helping to prolong or improve the lives of people with anal cancer, including those whose cancer has advanced to stage IV.

8 Nov 2018

U.S. Department of Defense grants 'Impact Award' to explore therapeutic options against advanced prostate cancer

The U.S. Department of Defense has granted the "Impact Award" to explore new therapeutic options against advanced prostate cancer - scientifically known as castration-resistant or hormone therapy resistant prostate cancer- to a multidisciplinary team of researchers made up of the Prostate Cancer Clinical Research Unit of the Spanish National Cancer Research Center, led by David Olmos, the Prostate Cancer Translational Research Group of the Vall d'Hebron Institute of Oncology, led by Joaquín Mateo, and the Genetics and Solid Tumors Laboratory of the University of Washington, led by Colin Pritchard.

7 Nov 2018

Lymph nodes serve as reservoirs of prolonged bacterial persistence during Mtb infection

Lymph nodes can contain large numbers of tuberculosis-causing bacteria and serve as long-term reservoirs of bacterial persistence, according to a study published November 1 in the open-access journal PLOS Pathogens by JoAnne Flynn of the University of Pittsburgh School of Medicine, and colleagues.

2 Nov 2018

New study to evaluate human immune system's response to influenza

The key to lasting protection against influenza may be in your bones. The cells that naturally protect you against illness originate and live in your bone marrow - and that is one spot where scientists will be looking to understand the human immune system's response to influenza in a groundbreaking new study led by the Human Vaccines Project.

1 Nov 2018

Radiotherapy can prolong survival in prostate cancer

A new major study from London has shown that radiotherapy can extend survival among patients with prostate cancer. The study shows that larger number of patients given standard therapy along with radiation therapy survived three years after the initiation of the study despite having a local spread of their cancer.

21 Oct 2018

Lymph Nodes News and Research

Researchers discover immune regulator that appears to dictate glioblastoma

Researchers identify marker protein that offers both diagnostic and therapeutic function

An essential reference for diagnostic ultrasonography and biopsy of the thyroid gland

Breast cancers more likely to metastasize in young women within 10 years of giving birth

Schizophrenia patients have higher levels of antibodies against Epstein-Barr virus, study shows

Yale researchers use arthritis medication to treat patient with disfiguring sarcoidosis

FDA approves new treatment for rare disease of the bone marrow and blood

New data from TAILORx trial confirms lack of chemo benefit regardless of race or ethnicity

Multigene test is a helpful decision making tool in breast cancer treatment, study shows

Earliest strain of plague bacteria found in neolithic Swedish mass grave

UMGCCC uses Gammapod radiotherapy to treat breast cancer patients

Lymph node ratio could predict survival in patients with oral cavity cancer

UAB research may point a path to more effective influenza vaccines

First modeling system developed for testing age-specific human immune responses to vaccines

Precisely targeted prostate cancer radiotherapy possible with nuclear medicine imaging

Advances in radiation treatment help prolong, improve lives of people with anal cancer

U.S. Department of Defense grants 'Impact Award' to explore therapeutic options against advanced prostate cancer

Lymph nodes serve as reservoirs of prolonged bacterial persistence during Mtb infection

New study to evaluate human immune system's response to influenza

Radiotherapy can prolong survival in prostate cancer

Immunology eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News